Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Stroke | Research

Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis

Authors: Hayoung Choi, Sang Hyuk Kim, Kyungdo Han, Tai Sun Park, Dong Won Park, Ji-Yong Moon, Sang-Heon Kim, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Hyun Lee

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background:

Although cardiovascular comorbidities negatively impact survival in patients with bronchiectasis, there is limited evidence to recommend exercise in this population. We aimed to evaluate whether exercise habit changes are related to reduced cardiovascular disease risk and explore an optimal exercise amount.

Methods:

This study identified 165,842 patients with newly diagnosed bronchiectasis during 2010–2016 who underwent two health examinations and were followed up until December 2020. The exposure was the change in weekly habits of moderate- or vigorous-intensity physical activity between the two examinations, classified into non-exercisers and exercisers (further classified into new exercisers, exercise dropouts, and exercise maintainers). The amount of exercise was measured using metabolic equivalents of task (MET). The outcome was the incidence of myocardial infarction (MI) or stroke.

Results:

During a mean of 6.2 ± 2.1 follow-up years, 4,233 (2.6%) and 3,745 (2.3%) of patients with bronchiectasis had MI or stroke, respectively. Compared to non-exercisers, exercisers had a significantly lower risk of MI or stroke by 9–28% (p < 0.001 for both). Among exercisers, exercise maintainers showed the lowest risk of MI (adjusted hazard ratio [aHR], 0.72; 95% confidence interval [CI], 0.64–0.81) and stroke (aHR, 0.72; 95% CI, 0.64–0.82) compared to non-exercisers. Regarding exercise amount, a significant risk reduction was observed only in patients with bronchiectasis who exercised for ≥ 500 MET-min/wk.

Conclusion:

Exercise was associated with a reduced risk of cardiovascular diseases in patients with bronchiectasis. In particular, the risk was lowest in exercise maintainers, and cardiovascular risk reduction was significant when exercising more than 500 MET-min/wk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47:186–93.CrossRef Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47:186–93.CrossRef
2.
go back to reference Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, Lee JS, Lee SW, Oh YM, Ra SW, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J. 2019;54:1900194.CrossRef Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, Lee JS, Lee SW, Oh YM, Ra SW, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J. 2019;54:1900194.CrossRef
3.
go back to reference Yang B, Choi H, Lim JH, Park HY, Kang D, Cho J, Lee JS, Lee SW, Oh YM, Moon JY, et al. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med. 2019;7:770.CrossRef Yang B, Choi H, Lim JH, Park HY, Kang D, Cho J, Lee JS, Lee SW, Oh YM, Moon JY, et al. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med. 2019;7:770.CrossRef
4.
go back to reference Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46:1805–7.CrossRef Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46:1805–7.CrossRef
5.
go back to reference Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017;14:377–84.CrossRef Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017;14:377–84.CrossRef
6.
go back to reference Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, Park HY, Ra SW, Oh YM, Chung SJ, et al. Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities. Sci Rep. 2021;11:7126.CrossRef Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, Park HY, Ra SW, Oh YM, Chung SJ, et al. Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities. Sci Rep. 2021;11:7126.CrossRef
7.
go back to reference Navaratnam V, Root AA, Douglas I, Smeeth L, Hubbard RB, Quint JK. Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non-Cystic Fibrosis Bronchiectasis: A General Population-based Study. Ann Am Thorac Soc. 2018;15:315–21.CrossRef Navaratnam V, Root AA, Douglas I, Smeeth L, Hubbard RB, Quint JK. Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non-Cystic Fibrosis Bronchiectasis: A General Population-based Study. Ann Am Thorac Soc. 2018;15:315–21.CrossRef
8.
go back to reference Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576–85.CrossRef Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576–85.CrossRef
9.
go back to reference Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109–16.CrossRef Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109–16.CrossRef
10.
go back to reference Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.CrossRef Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.CrossRef
11.
go back to reference Hill T, L Sullivan A A, Chalmers D, De Soyza J, Stuart Elborn A, Andres Floto J, Grillo R, Gruffydd-Jones L, Harvey K, A, S Haworth. C, et al: British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74:1–69.PubMed Hill T, L Sullivan A A, Chalmers D, De Soyza J, Stuart Elborn A, Andres Floto J, Grillo R, Gruffydd-Jones L, Harvey K, A, S Haworth. C, et al: British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74:1–69.PubMed
12.
go back to reference Lee AL, Hill CJ, Cecins N, Jenkins S, McDonald CF, Burge AT, Rautela L, Stirling RG, Thompson PJ, Holland AE. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial. Respir Res. 2014;15:44.CrossRef Lee AL, Hill CJ, Cecins N, Jenkins S, McDonald CF, Burge AT, Rautela L, Stirling RG, Thompson PJ, Holland AE. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial. Respir Res. 2014;15:44.CrossRef
13.
go back to reference Zanini A, Aiello M, Adamo D, Cherubino F, Zampogna E, Sotgiu G, Chetta A, Spanevello A. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy. Respiration. 2015;89:525–33.CrossRef Zanini A, Aiello M, Adamo D, Cherubino F, Zampogna E, Sotgiu G, Chetta A, Spanevello A. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy. Respiration. 2015;89:525–33.CrossRef
14.
go back to reference Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38:395–403.CrossRef Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38:395–403.CrossRef
15.
go back to reference Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021, 13(9):3206. Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021, 13(9):3206.
16.
go back to reference Choi H, Han K, Jung JH, Park SH, Kim SH, Kang HK, Sohn JW, Shin DW, Lee H. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2022;ciac411. Choi H, Han K, Jung JH, Park SH, Kim SH, Kang HK, Sohn JW, Shin DW, Lee H. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2022;ciac411.
17.
go back to reference Kim B. Korean version of international physical activity questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2006;27:348–57. Kim B. Korean version of international physical activity questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2006;27:348–57.
18.
go back to reference Ahn HJ, Lee SR, Choi EK, Han KD, Jung JH, Lim JH, Yun JP, Kwon S, Oh S, Lip GYH. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study. PLoS Med. 2021;18:e1003659.CrossRef Ahn HJ, Lee SR, Choi EK, Han KD, Jung JH, Lim JH, Yun JP, Kwon S, Oh S, Lip GYH. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study. PLoS Med. 2021;18:e1003659.CrossRef
19.
go back to reference Mônico-Neto M, Moreira Antunes HK, Dos Santos RVT, D’Almeida V, Alves Lino de Souza A, Azeredo Bittencourt LR, Tufik S. Physical activity as a moderator for obstructive sleep apnoea and cardiometabolic risk in the EPISONO study. Eur Respir J 2018, 52(4):1701972. Mônico-Neto M, Moreira Antunes HK, Dos Santos RVT, D’Almeida V, Alves Lino de Souza A, Azeredo Bittencourt LR, Tufik S. Physical activity as a moderator for obstructive sleep apnoea and cardiometabolic risk in the EPISONO study. Eur Respir J 2018, 52(4):1701972.
20.
go back to reference Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U, Group LPASW. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012;380:247–57.CrossRef Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U, Group LPASW. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012;380:247–57.CrossRef
21.
go back to reference Jeong SW, Kim SH, Kang SH, Kim HJ, Yoon CH, Youn TJ, Chae IH. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J. 2019;40:3547–55.CrossRef Jeong SW, Kim SH, Kang SH, Kim HJ, Yoon CH, Youn TJ, Chae IH. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J. 2019;40:3547–55.CrossRef
22.
go back to reference Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, Shin DW. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study. Front Nutr. 2021;8:739766.CrossRef Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, Shin DW. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study. Front Nutr. 2021;8:739766.CrossRef
23.
go back to reference Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, Kim EM, Suh SH, Shin HJ, Lee KR, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29:405–9.CrossRef Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, Kim EM, Suh SH, Shin HJ, Lee KR, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29:405–9.CrossRef
24.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRef
25.
go back to reference Lee H, Ryu J, Nam E, Chung SJ, Yeo Y, Park DW, Park TS, Moon J-Y, Kim T-H, Sohn JW. Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. European Respiratory Journal 2019, 54(5):1900804. Lee H, Ryu J, Nam E, Chung SJ, Yeo Y, Park DW, Park TS, Moon J-Y, Kim T-H, Sohn JW. Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. European Respiratory Journal 2019, 54(5):1900804.
26.
go back to reference Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. Coexisting COPD Increases Mortality in Patients With Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study. Allergy Asthma Immunol Res. 2020;12:821–31.CrossRef Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. Coexisting COPD Increases Mortality in Patients With Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study. Allergy Asthma Immunol Res. 2020;12:821–31.CrossRef
27.
go back to reference Navaratnam V, Millett ER, Hurst JR, Thomas SL, Smeeth L, Hubbard RB, Brown J, Quint JK. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax. 2017;72:161–6.CrossRef Navaratnam V, Millett ER, Hurst JR, Thomas SL, Smeeth L, Hubbard RB, Brown J, Quint JK. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax. 2017;72:161–6.CrossRef
28.
go back to reference Huang JT-J, Kuzmanova E, Dicker AJ, Keir HR, Finch S, Aliberti S, Fardon TC, Chalmers JD. Serum Desmosine Is Associated with Long-Term All-Cause and Cardiovascular Mortality in Bronchiectasis. Am J Respir Crit Care Med. 2020;202:897–9.CrossRef Huang JT-J, Kuzmanova E, Dicker AJ, Keir HR, Finch S, Aliberti S, Fardon TC, Chalmers JD. Serum Desmosine Is Associated with Long-Term All-Cause and Cardiovascular Mortality in Bronchiectasis. Am J Respir Crit Care Med. 2020;202:897–9.CrossRef
29.
go back to reference Gao Y-h, Liu S-x, Cui J-j, Wang L-y, Yin K-q, Wang L, Ding S-y. Guan W-j, Zhang G-j: Subclinical atherosclerosis in adults with steady-state bronchiectasis: a case-control study. Respir Med. 2018;134:110–6.CrossRef Gao Y-h, Liu S-x, Cui J-j, Wang L-y, Yin K-q, Wang L, Ding S-y. Guan W-j, Zhang G-j: Subclinical atherosclerosis in adults with steady-state bronchiectasis: a case-control study. Respir Med. 2018;134:110–6.CrossRef
30.
go back to reference Hansen C, Møller S, Ehlers T, Wickham KA, Bangsbo J, Gliemann L, Hellsten Y. Redox balance in human skeletal muscle-derived endothelial cells - Effect of exercise training. Free Radic Biol Med. 2022;179:144–55.CrossRef Hansen C, Møller S, Ehlers T, Wickham KA, Bangsbo J, Gliemann L, Hellsten Y. Redox balance in human skeletal muscle-derived endothelial cells - Effect of exercise training. Free Radic Biol Med. 2022;179:144–55.CrossRef
31.
go back to reference Wang D, Wang Y, Ma J, Wang W, Sun B, Zheng T, Wei M, Sun Y. MicroRNA-20a participates in the aerobic exercise-based prevention of coronary artery disease by targeting PTEN. Biomed Pharmacother. 2017;95:756–63.CrossRef Wang D, Wang Y, Ma J, Wang W, Sun B, Zheng T, Wei M, Sun Y. MicroRNA-20a participates in the aerobic exercise-based prevention of coronary artery disease by targeting PTEN. Biomed Pharmacother. 2017;95:756–63.CrossRef
32.
go back to reference Alcaraz-Serrano V, Gimeno-Santos E, Scioscia G, Gabarrus A, Navarro A, Herrero-Cortina B, Amaro R, Fernandez-Barat L, Torres A. Association between physical activity and risk of hospitalisation in bronchiectasis. Eur Respir J 2020, 55(6):1902138. Alcaraz-Serrano V, Gimeno-Santos E, Scioscia G, Gabarrus A, Navarro A, Herrero-Cortina B, Amaro R, Fernandez-Barat L, Torres A. Association between physical activity and risk of hospitalisation in bronchiectasis. Eur Respir J 2020, 55(6):1902138.
33.
go back to reference Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, et al. Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis. Am J Respir Crit Care Med. 2018;197:1410–20.CrossRef Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, et al. Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis. Am J Respir Crit Care Med. 2018;197:1410–20.CrossRef
34.
go back to reference Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J. 1982;103:1031–9.CrossRef Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J. 1982;103:1031–9.CrossRef
35.
go back to reference Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–8.CrossRef Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–8.CrossRef
36.
go back to reference Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031–8.CrossRef Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031–8.CrossRef
37.
go back to reference Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRef Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRef
38.
go back to reference Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput J-P, Chastin S, Chou R. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–62.CrossRef Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput J-P, Chastin S, Chou R. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–62.CrossRef
39.
go back to reference Teo PS, van Dam RM, Whitton C, Tan LWL, Forde CG. Consumption of Foods With Higher Energy Intake Rates is Associated With Greater Energy Intake, Adiposity, and Cardiovascular Risk Factors in Adults. J Nutr. 2021;151:370–8.CrossRef Teo PS, van Dam RM, Whitton C, Tan LWL, Forde CG. Consumption of Foods With Higher Energy Intake Rates is Associated With Greater Energy Intake, Adiposity, and Cardiovascular Risk Factors in Adults. J Nutr. 2021;151:370–8.CrossRef
Metadata
Title
Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis
Authors
Hayoung Choi
Sang Hyuk Kim
Kyungdo Han
Tai Sun Park
Dong Won Park
Ji-Yong Moon
Sang-Heon Kim
Tae-Hyung Kim
Jang Won Sohn
Ho Joo Yoon
Hyun Lee
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02202-7

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.